BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35813967)

  • 21. Breast and cervical cancer incidence and mortality trends in Russia 1980-2013.
    Barchuk A; Bespalov A; Huhtala H; Chimed T; Laricheva I; Belyaev A; Bray F; Anttila A; Auvinen A
    Cancer Epidemiol; 2018 Aug; 55():73-80. PubMed ID: 29843073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global trends in testicular cancer incidence and mortality.
    Rosen A; Jayram G; Drazer M; Eggener SE
    Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The characteristics of population mortality of the Russian Federation, the Central Federal Okrug and City of Moscow in 2020].
    Shchepin VO; Khabriev RU
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Mar; 29(2):189-193. PubMed ID: 33901352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The condition and tendencies of cervical carcinoma diagnostic in the Russian Federation].
    Tatarinova TA; Kosagovskaya II
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Nov; 29(6):1547-1555. PubMed ID: 34882331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Male sex workers in Moscow, Russia: a pilot study of demographics, substance use patterns, and prevalence of HIV-1 and sexually transmitted infections.
    Baral S; Kizub D; Masenior NF; Peryskina A; Stachowiak J; Stibich M; Moguilny V; Beyrer C
    AIDS Care; 2010 Jan; 22(1):112-8. PubMed ID: 20390488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future.
    Mohammadian M; Allah Bakeshei K; Mohammadian-Hafshejani A
    J Prev Med Hyg; 2020 Jun; 61(2):E259-E289. PubMed ID: 32803012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
    Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of High Risk Human Papillomaviruses in Patients With Cervical Cancer: An Evidence Based Study on Patients With Squamous Cell Dysplasia or Carcinoma for Evaluation of 23 Human Papilloma Virus Genotypes.
    Piroozmand A; Mostafavi Zadeh SM; Madani A; Soleimani R; Nedaeinia R; Niakan M; Avan A; Manian M; Moradi M; Eftekhar Z
    Jundishapur J Microbiol; 2016 Apr; 9(4):e32728. PubMed ID: 27279992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the effect of mass vaccination against hepatitis B in the Russian Federation].
    Klushkina VV; Kozhanova TV; Bazhazhina PG; Popova OE; Il'chenko LIu; Kiuregian KK; Mikhaĭlov MI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):42-8. PubMed ID: 23163035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020.
    Alekyan BG; Boytsov SA; Manoshkina EM; Ganyukov VI
    Kardiologiia; 2021 Dec; 61(12):4-15. PubMed ID: 35057716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National trends in incidence and geographic distribution of melanoma and keratinocyte carcinoma in the Russian Federation.
    Muntyanu A; Ghazawi FM; Pastukhova E; Zubarev A; Litvinov IV
    Front Med (Lausanne); 2023; 10():1188038. PubMed ID: 37547610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The mortality of population of the Russian Federation resulted due to alcohol toxic effect in 2010-2019].
    Sabaev AV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Nov; 29(6):1574-1577. PubMed ID: 34882336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.